Financials ReWalk Robotics Ltd.
Equities
LFWD
IL0011331076
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 USD | +0.64% | -0.63% | -12.75% |
Apr. 19 | ReWalk Robotics Ltd. Appoints Mike Swinford to the Board of Directors | CI |
Apr. 01 | Lifeward, CMS Working to Finalize Exoskeleton Medicare Payment Rate, CEO Says | MT |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 15.78 | 32.68 | 76.82 | 47.14 | 46.68 | 40.36 | - | - |
Enterprise Value (EV) 1 | 15.78 | 32.68 | 76.82 | 47.14 | 46.68 | 40.36 | 40.36 | 40.36 |
P/E ratio | -0.8 x | -1.61 x | -4.56 x | -2.45 x | -2.1 x | -2.71 x | -6.79 x | 13.6 x |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 3.24 x | 7.44 x | 12.9 x | 8.55 x | 3.37 x | 1.17 x | 0.77 x | 0.53 x |
EV / Revenue | 3.24 x | 7.44 x | 12.9 x | 8.55 x | 3.37 x | 1.17 x | 0.77 x | 0.53 x |
EV / EBITDA | - | - | - | - | - | - | - | - |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 1,044 | 3,537 | 8,922 | 8,860 | 8,575 | 8,497 | - | - |
Reference price 2 | 15.12 | 9.240 | 8.610 | 5.321 | 5.444 | 4.750 | 4.750 | 4.750 |
Announcement Date | 2/20/20 | 2/18/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 4.873 | 4.393 | 5.966 | 5.511 | 13.85 | 34.57 | 52.09 | 76.75 |
EBITDA | - | - | - | - | - | - | - | - |
EBIT 1 | -14.05 | -12 | -12.66 | -19.1 | -23.61 | -15.31 | -6.035 | 3.836 |
Operating Margin | -288.28% | -273.25% | -212.12% | -346.62% | -170.43% | -44.28% | -11.59% | 5% |
Earnings before Tax (EBT) 1 | -15.54 | -12.92 | -12.64 | -19.1 | -22.14 | -15.2 | -5.983 | 3.948 |
Net income 1 | -15.55 | -12.98 | -12.74 | -19.57 | -22.13 | -15.2 | -5.983 | 3.948 |
Net margin | -319.13% | -295.38% | -213.48% | -355.09% | -159.76% | -43.98% | -11.49% | 5.14% |
EPS 2 | -18.90 | -5.740 | -1.890 | -2.170 | -2.590 | -1.750 | -0.7000 | 0.3500 |
Free Cash Flow | - | - | - | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 2/20/20 | 2/18/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 1.972 | 1.242 | 0.876 | 1.57 | 0.886 | 2.179 | 1.23 | 1.337 | 4.403 | 6.884 | 5.548 | 6.681 | 9.259 | 13.08 | 12.8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -2.662 | -3.831 | - | -4.376 | -5.433 | -5.005 | - | -5.158 | -7.942 | -6.137 | -5.755 | -4.816 | -3.352 | -1.385 | - |
Operating Margin | -134.99% | -308.45% | - | -278.73% | -613.21% | -229.69% | - | -385.79% | -180.38% | -89.15% | -103.73% | -72.09% | -36.2% | -10.59% | - |
Earnings before Tax (EBT) 1 | -2.689 | -3.804 | - | -4.42 | -5.434 | -4.936 | - | -4.6 | -7.531 | -5.717 | -5.72 | -4.787 | -3.33 | -1.367 | - |
Net income 1 | -2.675 | -3.858 | - | -4.446 | -5.46 | -5.313 | - | -4.642 | -7.531 | -5.639 | -5.72 | -4.787 | -3.33 | -1.367 | - |
Net margin | -135.65% | -310.63% | - | -283.18% | -616.25% | -243.83% | - | -347.2% | -171.04% | -81.91% | -103.1% | -71.65% | -35.97% | -10.45% | - |
EPS 2 | -0.4200 | -0.4200 | -0.4900 | -0.4900 | -0.6300 | -0.6300 | -0.4900 | -0.5600 | -0.9100 | -0.9100 | -0.7000 | -0.5600 | -0.4200 | -0.1400 | -0.1400 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 11/10/21 | 2/24/22 | 5/13/22 | 8/9/22 | 11/7/22 | 2/23/23 | 5/11/23 | 8/11/23 | 11/14/23 | 2/27/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - | - |
Announcement Date | 2/20/20 | 2/18/21 | 2/24/22 | 2/23/23 | 2/27/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.75% | 40.36M | |
+1.84% | 24.07B | |
-6.34% | 16.75B | |
+8.69% | 13.7B | |
+10.34% | 10.18B | |
-17.75% | 2.06B | |
+6.38% | 1.79B | |
+10.93% | 589M | |
0.00% | 400M | |
+27.40% | 135M |
- Stock Market
- Equities
- LFWD Stock
- Financials ReWalk Robotics Ltd.